Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235

Nitin Ohri, Fenghai Duan, Mitchell MacHtay, Jeremy J. Gorelick, Bradley S. Snyder, Abass Alavi, Barry A. Siegel, Douglas W. Johnson, Jeffrey D. Bradley, Albert Denittis, Maria Werner-Wasik

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235'. Together they form a unique fingerprint.

Medicine & Life Sciences